- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01958879
Efficacy of Arthrocentesis by Injection of Ringer With or Without Corticosteroid in Treatment of Internal Derangement
October 4, 2014 updated by: Reza Tabrizi, Shiraz University of Medical Sciences
Treatment of Temporomandibular Disorder
The study aims to evaluate effectiveness of ringer injection with or without corticosteroid during arthrocentesis of the temporomandibular joint in the treatment of internal derangement of the temporomandibular joint (TMJ).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This prospective clinical study was approved by Local ethical committee and written informed consent will be obtained before the trial starts.
Criteria for selection of the patients was based on history and clinical findings characteristic of internal derangement.
All these patients were initially treated with NSAIDS for 1 week and occlusal splints for 1 month had failed to respond to these conservative treatments.
The patients with systemic problems which affect bone and joints,psychological problems ,history of maxillofacial fractures and orthognathic surgery were excluded from the study.
A total of 60 patients with TMJ internal derangement with failed conservative management, were subjected to TMJ arthrocentesis.
All arthrocentesis were performed by the same maxillofacial surgeon.
Subjects were randomly allocated into two groups (30 cases in each group).
Subjects in the group 1 received irrigation with Ringer solution and in the group 2 ,subjects underwent irrigation with Ringer solution with corticosteroid (Dexamethasone ) .Two examiners evaluated Temporomandibular disorder's signs ( mouth opening,click , crepitus and pain) before, one month and 6 months after arthrocentesis.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shiraz, Iran, Islamic Republic of
- Shiraz University of Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 80 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with clinical findings characteristic of internal derangement(clicking and joint pain lasting for more than 6 months) unilaterally or bilaterally and history of previous conservative drug therapy (NSAIDs and Muscle relaxant ),splint therapy and physiotherapy without improvement.
- Patients of both sexes between 15 to 80 year's old
- Patients who are willing for evaluation in 1 and 6 months after arthrocentesis
- Patients who are provided written consent form
Exclusion Criteria:
- Patient had systemic problems which affect bone and joints disease
- Patient with psychological problems
- Patient with history of maxillofacial fractures and orthognathic
- Patients who can not continue the study for private or social reasons
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ringer with corticosteroid
Intra-articular irrigation was performed under local anesthesia with subcutaneous injection of 1%lidocaine solution (0.6 to 0.9 mL anaesthetic solution )was injected to block the auriculotemporal nerve.
Then the skin on the TMJ was penetrated with a 21-gauge needle at the articular fossa followed by the injection of 3 mL Ringer solution to distend the joint space, pumping it in and out repeatedly.
Another 21-gauge needle was inserted into the distended compartment in the area of the articular eminence, and the superior joint space was irrigated with 200 mL Ringer solution, allowing a free flow through the first needle in the both groups .In this group patients received 1mg dexamethasone after finishing the irrigation .
|
200 mL Ringer solution+1mg dexamethasone after finishing the irrigation
|
|
Placebo Comparator: Ringer with out corticosteroid
Intra-articular irrigation was performed under local anesthesia with subcutaneous injection of 1%lidocaine solution (0.6 to 0.9 mL anaesthetic solution )was injected to block the auriculotemporal nerve.
Then the skin on the TMJ was penetrated with a 21-gauge needle at the articular fossa followed by the injection of 3 mL Ringer solution to distend the joint space, pumping it in and out repeatedly.
Another 21-gauge needle was inserted into the distended compartment in the area of the articular eminence, and the superior joint space was irrigated with 200 mL Ringer solution, allowing a free flow through the first needle in the both groups
|
200 mL Ringer solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain
Time Frame: 6 months
|
Pain will be assessed preoperatively and again at 1 and 6 months using a visual analogue scale
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
function
Time Frame: 6 months
|
Mouth opening was measured as the maximum interincisal distance in millimeters using a scale
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Reza Tabrizi, DMD, SUMS
- Study Director: Reza Tabrizi, DMD, SUMS
- Principal Investigator: Touba Karagah, DMD, SUMS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
October 5, 2013
First Submitted That Met QC Criteria
October 5, 2013
First Posted (Estimate)
October 9, 2013
Study Record Updates
Last Update Posted (Estimate)
October 7, 2014
Last Update Submitted That Met QC Criteria
October 4, 2014
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12345 (Danish Center for Healthcare Improvements)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
Clinical Trials on ringer with corticosteroid
-
HaEmek Medical Center, IsraelCompleted
-
Medical University of ViennaCompleted
-
University of MilanUnknownCirculatory FailureItaly
-
Hospices Civils de LyonCompleted
-
Sana'a UniversityCompleted
-
Bispebjerg HospitalCompleted
-
Rigshospitalet, DenmarkOctapharmaTerminated
-
K. C. RasmussenCompletedDisorders of Coagulation
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Karadeniz Technical UniversityCompletedArthrocentesis | Temporomandibular Disorders (TMD) | Hypermobility, Joint | Prolotherapy | Hypermobility Syndrome (Disorder) | Temporomandibular PainTurkey